Effectiveness of Upadacitinib Versus Other Advanced Therapies in Rheumatoid Arthritis After Tumor Necrosis Factor Inhibitor Use in the United States.
- DOI
- 10.1007/s40744-026-00885-8
- Published
- 2026 Nov 3
- Container
- Rheumatology and therapy
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40744-026-00885-8,
title = {Effectiveness of Upadacitinib Versus Other Advanced Therapies in Rheumatoid Arthritis After Tumor Necrosis Factor Inhibitor Use in the United States.},
author = {Charles-Schoeman C and Oelke K and Saffore CD and Kadakia A and Peng Y and Fang S and Markley G and Bergman MJ},
year = {2026},
journal = {Rheumatology and therapy},
doi = {10.1007/s40744-026-00885-8},
url = {https://doi.org/10.1007/s40744-026-00885-8}
}RIS
TY - JOUR TI - Effectiveness of Upadacitinib Versus Other Advanced Therapies in Rheumatoid Arthritis After Tumor Necrosis Factor Inhibitor Use in the United States. AU - Charles-Schoeman C AU - Oelke K AU - Saffore CD AU - Kadakia A AU - Peng Y AU - Fang S AU - Markley G AU - Bergman MJ PY - 2026 JO - Rheumatology and therapy DO - 10.1007/s40744-026-00885-8 UR - https://doi.org/10.1007/s40744-026-00885-8 ER -
APA
C, C., K, O., CD, S., A, K., Y, P., S, F., G, M., & MJ, B. (2026). Effectiveness of Upadacitinib Versus Other Advanced Therapies in Rheumatoid Arthritis After Tumor Necrosis Factor Inhibitor Use in the United States.. Rheumatology and therapy. https://doi.org/10.1007/s40744-026-00885-8
Source records
- pubmed · retrieved 2026-11-10T19:51:03.041Z
- europe-pmc · retrieved 2026-11-10T19:51:03.059Z